CV Sciences, Inc. to Host Investor Update Call

Company to Provide Updates to Shareholders and Prospective Investors on September 12th at 1:15pm PT/4:15pm ET

LAS VEGAS, NV -- (Marketwired) -- 09/06/17 -- CV Sciences, Inc., (OTCQB: CVSI) (the "Company" or "CV Sciences"), market-leading supplier and manufacturer of hemp-derived cannabidiol (CBD) consumer products and developer of specialty pharmaceutical therapeutics, today announced that it will host a shareholder update conference call on Tuesday, September 12, 2017 at 1:15 PM PT/4:15PM ET.

CV Sciences' Chief Financial Officer, Joseph Dowling, will lead the call to provide shareholders and prospective investors highlights of the Company's latest updates and accomplishments during 2017 and strategic initiatives moving forward.

Participants may access the call by dialing 1-877-407-8293 (United States) or 1-201-689-8349 (International). If you are unable to participate in the call at this time, a replay will be available for 14 days starting on September 12, 2017, at approximately 7:30AM PT/10:30 PM ET. To access the replay, please dial 877-877-660-6853 in the U.S. and 201-612-7415 for international callers. The conference ID# is 13670027.

About CV Sciences, Inc.

CV Sciences, Inc. (OTCQB: CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and a consumer product division in manufacturing, marketing and selling plant-based CBD products to a range of market sectors. CV Sciences, Inc. has primary offices and facilities in San Diego, California and Las Vegas, Nevada. Additional information is available from or by visiting


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Robert Haag
Managing Director
IRTH Communications

Source: CV Sciences, Inc.